ISSN: 0037-1963

Journal Home

Journal Guideline

Seminars in Hematology Q1 Unclaimed

W.B. Saunders United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Seminars in Hematology is a journal indexed in SJR in Hematology with an H index of 103. It has an SJR impact factor of 1,275 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,275.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Hematology (Q1)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

1,275

SJR Impact factor

103

H Index

39

Total Docs (Last Year)

93

Total Docs (3 years)

2331

Total Refs

351

Total Cites (3 years)

81

Citable Docs (3 years)

4.13

Cites/Doc (2 years)

59.77

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Journal of Hematology and Oncology Q1
Blood Q1
Blood Cancer Journal Q1
The Lancet Haematology Q1
Leukemia Q1

Compare this journals

Aims and Scope

Best articles by citations

Flow cytometric analysis of lymphomas and lymphoproliferative disorders

Impact of fatigue on quality of life in oncology patients

Clinical experience with recombinant human thrombopoietin in chemotherapy-induced thrombocytopenia

Developmental therapeutics for multiple myeloma[mdash ]A road map for the future

Cell function-based flow cytometry

Flow cytometric enumeration and immunophenotyping of hematopoietic stem and progenitor cells

Current status and perspectives of therapy for acute myeloid leukemia

Bacterial contamination of platelet concentrates: Incidence, significance, and prevention

Biologic and structural differences of thrombopoietic growth factors

Clinical implications of recurring chromosomal and associated molecular abnormalities in acute lymphoblastic leukemia

Introduction to flow cytometry

Introduction to therapies in multiple myeloma

SHOW MORE ARTICLES

Laparoscopic splenectomy in chronic idiopathic thrombocytopenic purpura

Flow cytometry in analysis of cell cycle and apoptosis

Flow cytometry in human leukocyte antigen testing

Active site-inhibited seven: Mechanism of action including signal transduction

Flow cytometry in the diagnosis of acute leukemia

Prevention of transfusion-associated graft-versus-host disease by inactivation of T cells in platelet components

Structural and functional characterization of B-domain deleted recombinant factor VIII

Anticomplement Treatment in Atypical and Typical Hemolytic Uremic Syndrome

Standard-dose therapy for multiple myeloma: The Southwest Oncology Group experience

Management of idiopathic thrombocytopenic purpura in pregnancy

Use of recombinant factor VIIa (NovoSeven[reg ]) in patients with Glanzmann thrombasthenia

Management of cancer-related anemia: Epoetin alfa and quality of life